Vaquero J, Zurita M, Coca S, Oya S, Morales C
Laboratory of Experimental Neuro-oncology, Neuroscience Research Unit of the Mapfre-Medicine Foundation, Puerta de Hierro Clinic Hospital, Autonomous University, Madrid, Spain.
Surg Neurol. 2000 Sep;54(3):229-34; discussion 234. doi: 10.1016/s0090-3019(00)00303-7.
Keeping in mind that oligodendrogliomas have unpredictable biological behavior, the aim of this study is to investigate the prognostic significance of VEGF expression and microvessel density in a homogeneous series of low-grade oligodendrogliomas.
For this study 36 patients with a low-grade oligodendroglioma treated by surgical resection and radiotherapy were selected. At the time of surgery, in all cases the Karnofsky Performance Scale (KPS) score was more than 70, and the study of the resected tumor disclosed a Ki-67/MIB-1 labeling index (MBI-1 LI) less than 1%. In this homogeneous series, immunohistochemical studies were performed using monoclonal antibodies against VEGF in order to study the expression of this cytokine, and against vascular endothelial CD-34 antigen, in order to identify microvessels.
Our results show that in contrast to low-grade astrocytomas, low-grade oligodendrogliomas lacked immunoreactive VEGF. Oligodendrogliomas with low vascular density (less than 20 microvessels per microscopical field, at 200 x) or high vascular density (more than 100 microvessels per field, at 200 x) were identified, but this factor had no influence on the survival rate of patients. On the other hand, analysis of the present series showed that clinical factors, such as age or extent of surgical resection, were not significantly associated with survival.
In contrast to low-grade astrocytomas, the angiogenesis score of low-grade oligodendrogliomas (counting the number of microvessels in tumor tissue) adds little information to help predict tumor behavior.
鉴于少突胶质细胞瘤具有不可预测的生物学行为,本研究旨在探讨血管内皮生长因子(VEGF)表达和微血管密度在一系列同质的低级别少突胶质细胞瘤中的预后意义。
本研究选取了36例接受手术切除及放疗的低级别少突胶质细胞瘤患者。手术时,所有患者的卡氏功能状态评分(KPS)均高于70分,且对切除肿瘤的研究显示,Ki-67/MIB-1标记指数(MBI-1 LI)低于1%。在这一同质系列研究中,采用抗VEGF单克隆抗体进行免疫组化研究以探讨该细胞因子的表达情况,并采用抗血管内皮CD-34抗原的抗体来识别微血管。
我们的结果显示,与低级别星形细胞瘤不同,低级别少突胶质细胞瘤缺乏免疫反应性VEGF。识别出了血管密度低(在200倍显微镜下每个视野少于20个微血管)或血管密度高(在200倍显微镜下每个视野多于100个微血管)的少突胶质细胞瘤,但这一因素对患者生存率并无影响。另一方面,对本系列研究的分析表明,年龄或手术切除范围等临床因素与生存率并无显著关联。
与低级别星形细胞瘤不同,低级别少突胶质细胞瘤的血管生成评分(计算肿瘤组织中的微血管数量)对预测肿瘤行为帮助不大。